Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 19/2023

Inhalt (60 Artikel)

Research

Identification of glycogene-based prognostic signature and validation of B3GNT7 as a potential biomarker and therapeutic target in breast cancer

Xin Wang, Yida Wang, Xuanming Chen, Yufei He, Xunyu Zhou, Sitong Jiao, Zilin Zhu, Chuanfang Wu, Jinku Bao

Research

Automated bone marrow cell classification through dual attention gates dense neural networks

Kaiyi Peng, Yuhang Peng, Hedong Liao, Zesong Yang, Wenli Feng

Research

Evaluation of survival outcome and prognostic factors for oral cavity cancer treated with volumetric arc therapy

Himanshu Mishra, Shreya Singh, Ritusha Mishra, Ankita Pandey, Abhijit Mandal, Ekta Prakash, Ganeshkumar Patel, Manav Shah, Tej Bali Singh

Open Access Research

Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study

Gaëtan-Romain Joliat, Sérgio Gaspar-Figueiredo, Ismail Labgaa, Dionisios Vrochides, Julie Perinel, Mustapha Adham, Nicolas Demartines, Markus Schäfer

Open Access Research

Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry

Jörg Andreas Müller, Karl-Stefan Delank, Kevin Laudner, Ian Wittenberg, Alexander Zeh, Dirk Vordermark, Daniel Medenwald

Open Access Research

Principles of oncology taught in a one-week course

Matthias Oettle, Marcel Büttner, Marie Forster, Laura Gajdi, Johannes Mücke, Alexander Nieto, Sonja Heuser, Johanna Huber, Franziska Walter, Stefanie Corradini, Maximilian Niyazi, Claus Belka, Martin Dreyling, Martin R. Fischer, Daniel F. Fleischmann

Open Access Research

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma

Hannah C. Puhr, Clemens C. Weirauch, Flora Selimi, Karin Oberreiter, Martin A. Dieterle, Gerd Jomrich, Sebastian F. Schoppmann, Gerald W. Prager, Anna S. Berghoff, Matthias Preusser, Aysegül Ilhan-Mutlu

Research

Cancer risks in patients with psoriasis administered biologics therapy: a nationwide population-based study

Joon Min Jung, Ye-Jee Kim, Sung Eun Chang, Mi Woo Lee, Chong Hyun Won, Woo Jin Lee

Open Access Research

Herpes zoster is not associated with subsequent gastrointestinal cancer: data from over 200,000 outpatients in Germany

Catherine Leyh, Christoph Roderburg, Tom Luedde, Sven H. Loosen, Karel Kostev

Open Access Research

Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer

Monika Bratova, Jana Skrickova, Magda Matusikova, Karolina Hrabcova, Libor Havel, Leona Koubkova, Michal Hrnciarik, Jana Krejci, Ondrej Fischer, Martin Svaton, Kristian Brat

Research

Breast cancer prediction using different machine learning methods applying multi factors

Elham Nazari, Hamid Naderi, Mahla Tabadkani, Reza ArefNezhad, Amir Hossein Farzin, Mohammad Dashtiahangar, Majid Khazaei, Gordon A. Ferns, Amin Mehrabian, Hamed Tabesh, Amir Avan

Research

Multi-omics analysis revealed the mitochondrial-targeted drug combination to suppress the development of lung cancer

Chaoqun Li, Yanfei Zhang, Qing Xia, Bingjie Hao, Yifan Hong, Liduo Yue, Tiansheng Zheng, Ming Li, Lihong Fan

Open Access Research

Quality of breaking bad news to patients diagnosed with neoplasia of the uterine cervix

Pia von Blanckenburg, Christhardt Köhler, Anja Petzel, Anne Jülicher, Viola Schneider, Achim Schneider

Open Access Research

Radioactive nanosized colloids and indocyanine green identify the same sentinel lymph nodes in oral squamous cell carcinoma

Lukas Hingsammer, Daphne Schönegg, Thomas Gander, Martin Lanzer

Research

Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma

Wenping Lin, Lianghe Lu, Rongliang Zheng, Shasha Yuan, Shaohua Li, Yihong Ling, Wei Wei, Rongping Guo

Research

Alteration of serum bile acids in non-small cell lung cancer identified by a validated LC–MS/MS method

Tongxin Yin, Ke Liu, Ying Shen, Yi Wang, Qiankun Wang, Tingting Long, Jiaoyuan Li, Liming Cheng

Research

Hematopoietic stem cells suppress proliferation and enhance differentiation of leukemia cells through regulating apoptotic and inflammatory genes

Bo Li, Can Can, Wancheng Liu, Xiaodong Guo, Hanyang Wu, Yihong Wei, Jinting Liu, Xinyu Yang, Wenbo Jia, Daoxin Ma

Open Access Research

Comparative analysis of diagnostic ultrasound and histopathology for detecting cervical lymph node metastases in head and neck cancer

Karl Christoph Sproll, Iryna Hermes, Gerd Felder, Nikolas H. Stoecklein, Maximilian Seidl, Peter Kaiser, Wolfgang Kaisers

Research

CCR5/CCL5 axis is linked to a poor outcome, and inhibition reduces metastasis in oral squamous cell carcinoma

Wilfredo Alejandro González-Arriagada, Ricardo D. Coletta, Carlo Lozano-Burgos, Cynthia García, Jaime Maripillán, Francisca Alcayaga-Miranda, Bastián Godínez-Pacheco, Sebastián Oyarce-Pezoa, René Martínez-Flores, Isaac E. García

Open Access Research

One bout of endurance exercise does not change gene expression or proliferation in a C26 colon carcinoma in immunocompetent mice

Nik Mahnic, Alessia Geremia, Tobias Straub, Sabrina Zorzato, Martin Schönfelder, Irene von Lüttichau, Katja Steiger, Maximilian Michael Saller, Bert Blaauw, Henning Wackerhage

Research

Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization

Xiao Zheng, Nan Hu, Jiamin Liu, Kailu Zhao, Huimin Li, Jiahao Wang, Mingxuan Zhang, Le Zhang, Li Song, Yuanjing Lyu, Meng Cui, Ling Ding, Jintao Wang

Research

In search of new stratification strategies: tissue proteomic profiling of papillary thyroid microcarcinoma in patients with localized disease and lateral neck metastases

Filip Matovinovic, Rudjer Novak, Stela Hrkac, Grgur Salai, Marko Mocibob, Marija Pranjic, Andro Košec, Vladimir Bedekovic, Lovorka Grgurevic

Research

Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer

Sousuke Kubo, Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, Ayami Kaneko, Hisashi Hashimoto, Shuhei Teranishi, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Makoto Kudo, Takeshi Kaneko

Research

The value of an apparent diffusion coefficient histogram model in predicting meningioma recurrence

Tao Han, Xianwang Liu, Mengyuan Jing, Yuting Zhang, Liangna Deng, Bin Zhang, Junlin Zhou

Open Access Research

Diagnostic accuracy of contrast-enhanced computed tomography in assessing cervical lymph node status in patients with oral squamous cell carcinoma

Ann-Kristin Struckmeier, Ebrahim Yekta, Abbas Agaimy, Markus Kopp, Mayte Buchbender, Tobias Moest, Rainer Lutz, Marco Kesting

Research

Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma

Xi Tian, Shuxuan Zhu, Wangrui Liu, Xinrui Wu, Gaomeng Wei, Ji Zhang, Aihetaimujiang Anwaier, Cong chen, Shiqi Ye, Xiangxian Che, Wenhao Xu, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye

Open Access Research

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis

Gabriela G. F. van der Schoot, Harm L. Ormel, Nico-Derk L. Westerink, Johan B. Wempe, Joop D. Lefrandt, Anne M. May, Aline H. Vrieling, Coby Meijer, Jourik A. Gietema, Annemiek M. E. Walenkamp

Research

Using machine learning to identify patients at high risk of developing low bone density or osteoporosis after gastrectomy: a 10-year multicenter retrospective analysis

Yanfei Zhu, Yuan Liu, Qi Wang, Sen Niu, Lanyu Wang, Chao Cheng, Xujin Chen, Jinhui Liu, Songyun Zhao

Research

Components of the JNK–MAPK pathway play distinct roles in hepatocellular carcinoma

Jijun Yu, Xinying Li, Junxia Cao, Ting Zhu, Shuifeng Liang, Le Du, Meng Cao, Haitao Wang, Yaolin Zhang, Yinxi Zhou, Beifen Shen, Jiannan Feng, Jiyan Zhang, Jing Wang, Jianfeng Jin

Open Access Research

Emerging markers of cancer cachexia and their relationship to sarcopenia

Melanie Lipshitz, J. Visser, R. Anderson, D. G. Nel, T. Smit, H. C. Steel, B. Rapoport

Research

Explore the alterations of downstream molecular pathways caused by ARID1A mutation/knockout in human endometrial cancer cells

Baoling Xing, Xiaoying Zhang, Xia Gu, Lintao Xiang, Cuiping Wang, Yueling Jin

Research

Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma

Haoling Li, Jing Li, Xiangyu Qu, Hengwen Dai, Junjie Liu, Mengxi Ma, Jian Wang, Wei Dong, Wenrui Wang

Research

Salivary metabolites as novel independent predictors of radiation pneumonitis

Sachika Shiraishi, Masahiro Sugimoto, Koichi Tokuuye

Research

Cordycepin remodels the tumor microenvironment of colorectal cancer by down-regulating the expression of PD-L1

Shaoxian Wu, Weiwei Fang, Lujun Chen, Chen Feng, Rongzhang Chen, Hanjie Ying, Xiao Zheng, Jingting Jiang

Open Access Research

Global research trends in tumor stem cell-derived exosomes and tumor microenvironment: visualization biology analysis

Ziwei Guo, Gang Wang, Zhangjun Yun, Yanbo Li, Bohao Huang, Qian Jin, Yue Chen, Luchun Xu, Wenliang Lv

Research

Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors

Gabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, Yang Lu, Mehmet Altan, Yan Zhou, Dan Zhao, Enrico N. De Toni, Helga-Paula Török, Bryan J. Schneider, Anam Khan, Anusha S. Thomas, Hao Chi Zhang, Mehnaz A. Shafi, Yinghong Wang

Open Access Review

Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application

Natalia Banaszek, Dominika Kurpiewska, Katarzyna Kozak, Piotr Rutkowski, Paweł Sobczuk

Review

Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer

Rodrigo Santiago Moreira, Marillya Morais da Silva, César Freire de Melo Vasconcelos, Thiago Douberin da Silva, Gabriel Guerra Cordeiro, Luiz Alberto Reis Mattos-Jr, Maira Galdino da Rocha Pitta, Moacyr Jesus Barreto de Melo Rêgo, Michelly Cristiny Pereira

Review

Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis

Sisi Wang, Lufeng Deng, Jiaren Chen, Yilin Li, Yangyan Zhong, Youquan Wang, Hong Cao

Review

Polymeric immunoglobulin receptor (pIgR) in cancer

Jisu Chae, Jinny Choi, Junho Chung

Review

Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review

Mengfei Sheng, Yuanyuan Zhang, Yaoyun Wang, Weiyi Liu, Xingyu Wang, Tiaoying Ke, Pingyang Liu, Sihan Wang, Wei Shao

Review

Melittin: a possible regulator of cancer proliferation in preclinical cell culture and animal models

Shafiul Haque, Arif Hussain, Hemant Joshi, Ujjawal Sharma, Bunty Sharma, Diwakar Aggarwal, Isha Rani, Seema Ramniwas, Madhu Gupta, Hardeep Singh Tuli

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.